
Huron Consulting Group’s second quarter results for 2025 were met with a negative market reaction, as revenue fell slightly below Wall Street expectations, despite year-over-year growth across all segments. Management attributed the quarter’s performance to ongoing demand in healthcare, education, and commercial consulting services, while highlighting softness in digital project conversions within healthcare. CEO Mark Hussey acknowledged the impact of recent regulatory legislation on client behavior, noting that the One Big Beautiful Bill Act has driven health systems to prioritize immediate financial stability over longer-term digital transformation initiatives.
Is now the time to buy HURN? Find out in our full research report (it’s free).
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
In the quarters ahead, our analysts will track (1) the pace at which delayed healthcare digital transformation projects resume, (2) successful integration and margin impact of the Eclipse Insights and Treliant acquisitions, and (3) continued record sales conversion in the education segment despite regulatory uncertainty. The sustainability of improved pipeline visibility and margin recovery will be key themes.
Huron currently trades at $132.20, in line with $132.38 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Jul-29 | |
| Jul-29 | |
| Jul-28 | |
| Jul-28 | |
| Jul-27 | |
| Jul-14 | |
| Jun-29 | |
| Jun-22 | |
| Jun-03 | |
| May-06 | |
| May-05 | |
| May-05 | |
| Apr-21 | |
| Apr-14 | |
| Mar-31 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite